The loudness dependence of the auditory evoked potential (LDAEP) in schizophrenia, bipolar disorder, major depressive disorder, anxiety disorder, and healthy controls

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 34, Issue 2, 2010, Pages 313-316

  Park, Young Min ^a,c   Lee, Seung Hwan ^a,c   Kim, Sangrae ^b,c   Bae, Sung Man ^a,c  

^a Inje University   (South Korea)

^b Yonsei University   (South Korea)

^c Clinical Emotion and Cognition Research Laboratory   (South Korea)

Author keywords

Electrophysiology; LDAEP; Loudness dependence of the auditory evoked potential; N100; Serotonin

Indexed keywords

ADULT; AGE DISTRIBUTION; ANXIETY DISORDER; ARTICLE; AUDITORY RESPONSE; BIPOLAR DISORDER; CONTROLLED STUDY; EVOKED AUDITORY RESPONSE; GENERALIZED ANXIETY DISORDER; HUMAN; LOUDNESS; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; PANIC; POSTTRAUMATIC STRESS DISORDER; PSYCHOLOGIC ASSESSMENT; PSYCHOLOGICAL RATING SCALE; SCHIZOPHRENIA; STRENGTH;

ACOUSTIC STIMULATION; ADOLESCENT; ADULT; ANALYSIS OF VARIANCE; ANXIETY DISORDERS; BIPOLAR DISORDER; DEPRESSIVE DISORDER, MAJOR; ELECTROENCEPHALOGRAPHY; EVOKED POTENTIALS, AUDITORY; FEMALE; HUMANS; LOUDNESS PERCEPTION; MALE; MIDDLE AGED; REACTION TIME; SCHIZOPHRENIA; YOUNG ADULT;

EID: 77649275475     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2009.12.004     Document Type: Article

References (23)

1. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV) 1994, American Psychiatric Association, American Psychiatric Press, Washington, DC.
2. Brocke B., Beauducel A., John R., Debener S., Heilemann H. Sensation seeking and affective disorders: characteristics in the intensity dependence of acoustic evoked potentials. Neuropsychobiology 2000, 41:24-30.
3. Buchsbaum M., Goodwin F., Murphy D., Borge G. AER in affective disorders. Am J Psychiatry 1971, 128:19-25.
4. Frist M.B., Gibbons M., Spitzer R.L., Williams J.B.W. Structure Clinical Interview for DSM-IV Axis II Personality Disorders 1997, Biometrics Research, New York State Psychiatric Institute, New York.
5. Gallinat J., Bottlender R., Juckel G., Munke-Puchner A., Stotz G., Kuss H.J., et al. The loudness dependency of the auditory evoked N1/P2-component as a predictor of the acute SSRI response in depression. Psychopharmacology (Berl) 2000, 148:404-411.
6. Gudlowski Y., Ozgürdal S., Witthaus H., Gallinat J., Hauser M., Winter C., et al. Serotonergic dysfunction in the prodromal, first-episode and chronic course of schizophrenia as assessed by the loudness dependence of auditory evoked activity. Schizophr Res 2009, 109:141-147.
7. Hegerl U., Juckel G. Intensity dependence of auditory evoked potentials as an indicator of central serotonergic neurotransmission: a new hypothesis. Biol Psychiatry 1993, 33:173-187.
8. Hensch T., Herold U., Brocke B. An electrophysiological endophenotype of hypomanic and hyperthymic personality. J Affect Disord 2007, 101:13-26.
9. Juckel G., Schmidt L.G., Rommelspacher H., Hegerl U. The Tridimensional Personality Questionnaire and the intensity dependence of auditory evoked dipole source activity. Biol Psychiatry 1995, 37:311-317.
10. Juckel G., Hegerl U., Molnár M., Csépe V., Karmos G. Auditory evoked potentials reflect serotonergic neuronal activity - a study in behaving cats administered drugs acting on 5-HT1A autoreceptors in the dorsal raphe nucleus. Neuropsychopharmacology 1999, 21:710-716.
11. Juckel G., Gallinat J., Riedel M., Sokullu S., Schulz C., Möller H.J., et al. Serotonergic dysfunction in schizophrenia assessed by the loudness dependence measure of primary auditory cortex evoked activity. Schizophr Res 2003, 64:115-124.
12. Juckel G., Gudlowski Y., Müller D., Ozgürdal S., Brüne M., Gallinat J., et al. Loudness dependence of the auditory evoked N1/P2 component as an indicator of serotonergic dysfunction in patients with schizophrenia - a replication study. Psychiatry Res 2008, 158:79-82.
13. Linka T., Müller B.W., Bender S., Sartory G. The intensity dependence of the auditory evoked N1 component as a predictor of response to citalopram treatment in patients with major depression. Neurosci Lett 2004, 367:375-378.
14. Linka T., Müller B.W., Bender S., Sartory G., Gastpar M. The intensity dependence of auditory evoked ERP components predicts responsiveness to reboxetine treatment in major depression. Pharmacopsychiatry 2005, 38:139-143.
15. Linka T., Sartory G., Bender S., Gastpar M., Müller B.W. The intensity dependence of auditory ERP components in unmedicated patients with major depression and healthy controls. An analysis of group differences. J Affect Disord 2007, 103:139-145.
16. Linka T., Sartory G., Wiltfang J., Müller B.W. Treatment effects of serotonergic and noradrenergic antidepressants on the intensity dependence of auditory ERP components in major depression. Neurosci Lett 2009, 463:26-30.
17. Norra C., Mrazek M., Tuchtenhagen F., Gobbelé R., Buchner H., Sass H., et al. Enhanced intensity dependence as a marker of low serotonergic neurotransmission in borderline personality disorder. J Psychiatr Res 2003, 37:23-33.
18. Semlitsch H.V., Anderer P., Schuster P., Presslich O. A solution for reliable and valid reduction of ocular artifacts, applied to the P300 ERP. Psychophysiology 1986, 23:695-703.
19. Senkowski D., Linden M., Zubrägel D., Bär T., Gallinat J. Evidence for disturbed cortical signal processing and altered serotonergic neurotransmission in generalized anxiety disorder. Biol Psychiatry 2003, 53:304-314.
20. Strobel A., Debener S., Schmidt D., Hünnerkopf R., Lesch K.P., Brocke B. Allelic variation in serotonin transporter function associated with the intensity dependence of the auditory evoked potential. Am J Med Genet B Neuropsychiatr Genet 2003, 118B:41-47.
21. Vawter M.P., Freed W.J., Kleinman J.E. Neuropathology of bipolar disorder. Biol Psychiatry 2000, 48:486-504.
22. Wiste A.K., Arango V., Ellis S.P., Mann J.J., Underwood M.D. Norepinephrine and serotonin imbalance in the locus coeruleus in bipolar disorder. Bipolar Disord 2008, 10:349-359.
23. Woods S.W. Chlorpromazine equivalent doses for the newer atypical antipsychotics. J Clin Psychiatry 2003, 64:663-667.